A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
Clinical trial NCT04657991 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04657991
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2026-01-12
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.